Source: Eur Respir J 2002; 19: 944-951
Disease area: Respiratory critical care, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Prats E., Dorca J., Pujol M., Garcia L., Barreiro B., Verdaguer R., Gudiol F., Manresa F.. Effects of antibiotics on protected specimen brush sampling in ventilator-associated pneumonia. Eur Respir J 2002; 19: 944-951

Member's Comments

No comment yet.

Related content which might interest you: Microbial investigation in ventilator-associated pneumonia Source: Eur Respir J 2001; 17: 791-801 Year: 2001 Pharmacokinetic optimisation of β-lactams for the treatment of ventilator-associated pneumonia Source: Eur Respir Rev 2007; 16: 45-49 Year: 2007 Ventilator-associated pneumonia due to colistin susceptible-only microorganisms Source: Eur Respir J 2007; 30: 307-313 Year: 2007 Diagnosis and treatment of nosocomial pneumonia in ALI/ARDS patients Source: Eur Respir J 2003; 22: 77S-83S Year: 2003 Determinants of prescription and choice of empirical therapy for hospital-acquired and ventilator-associated pneumonia Source: Eur Respir J 2011; 37: 1332-1339 Year: 2011 Antibiotic treatment for nosocomial pneumonia Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=211 Year: 2004 Diagnosis of nosocomial pneumonia in medical ward: repeatability of the protected specimen brush Source: Eur Respir J 2001; 18: 157-163 Year: 2001 How to prevent ventilator-associated pneumonia Source: Annual Congress 2013 –PG3 Infections and critical patients: emerging problems and clinical strategies Year: 2013 Importance of appropriate initial antibiotic therapy and de-escalation in the treatment of nosocomial pneumonia Source: Eur Respir Rev 2007; 16: 33-39 Year: 2007 Routine tracheal aspirates and adequacy of initial antibiotherapy of ventilator-associated pneumonia Source: Eur Respir J 2003; 22: Suppl. 45, 13s Year: 2003 Intermittent suction of oral secretion can reduce ventilator-associated pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 182s Year: 2006 Impact of reducing antibiotic treatment on inflammation among patients with community-acquired pneumonia. Source: International Congress 2019 – Prognosis in bacterial and viral pneumonia Year: 2019 Procalcitonin for reduced antibiotic exposure in ventilator-associated pneumonia: a randomised study Source: Eur Respir J 2009; 34: 1364-1375 Year: 2009 The approach to antibiotic treatment in community-acquired pneumonia Source: Annual Congress 2008 - MP14 - The approach to antibiotic treatment in community-acquired pneumonia Year: 2008 In the name of ventilator-associated pneumonia prevention: lung microbiota blown away by colistin! Source: Eur Respir J 2015; 46: 1544-1547 Year: 2015 Aerosolised treatment for VAP Source: Eur Respir Mon 2011; 53: 54-65 Year: 2011 Reducing antibiotics use for ventilator-associated pneumonia in brain-injured patients Source: Eur Respir J 2016; 47: 1060-1061 Year: 2016 Oral antibiotics prior to hospitalisation for community-acquired pneumonia Source: Eur Respir J 2008; 31: 478-479 Year: 2008 Duration of antibiotic therapy in hospitalised patients with community-acquired pneumonia Source: Eur Respir J 2010; 36: 128-134 Year: 2010 Empiric antimicrobial therapy for ventilator-associated pneumonia after brain injury Source: Eur Respir J 2016; 47: 1219-1228 Year: 2016